13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001012975-24-000483
Total Value
$906.8M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 1,202,804 | $690.1M | 76.11% |
| 2 | ISHARES TR | 46429B598 | 2,425,144 | $141.9M | 15.65% |
| 3 | VANGUARD INTL EQUITY INDEX F | 922042775 | 507,600 | $32.0M | 3.53% |
| 4 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $14.7M | 1.62% |
| 5 | ORIC PHARMACEUTICALS INC | ORIC | 989,410 | $10.1M | 1.12% |
| 6 | ALECTOR INC | ALEC | 1,307,858 | $6.1M | 0.67% |
| 7 | PMV PHARMACEUTICALS INC | PMVP | 2,627,643 | $3.9M | 0.43% |
| 8 | 23ANDME HOLDING CO | 90138Q108 | 10,243,122 | $3.6M | 0.40% |
| 9 | TENAYA THERAPEUTICS INC | TNYA | 1,015,705 | $2.0M | 0.22% |
| 10 | RAPT THERAPEUTICS INC | 75382E109 | 657,899 | $1.3M | 0.15% |
| 11 | SURROZEN INC | SRZNW | 87,696 | $1.1M | 0.12% |
| 12 | SURROZEN INC | SRZNW | 170,833 | $1,760 | 0.00% |